Perspective from Cynthia Matossian, MD, FACS
Perspective from Elizabeth Yeu, MD
Perspective from John A. Hovanesian, MD, FACS
Source:

Newman-Casey PA, et al. Ophthalmology. 2017;doi:10.1016/j.ophtha.2017.05.024.

July 19, 2017
3 min read
Save

Eye care providers prescribe most brand-name medications

Perspective from Cynthia Matossian, MD, FACS
Perspective from Elizabeth Yeu, MD
Perspective from John A. Hovanesian, MD, FACS
Source:

Newman-Casey PA, et al. Ophthalmology. 2017;doi:10.1016/j.ophtha.2017.05.024.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eye care providers prescribe more brand-name drugs than other health care specialists, according to Medicare Part D data.

In a retrospective cross-sectional study quantifying eye care medication costs by researchers at the University of Michigan Kellogg Eye Center, ophthalmologists were found to file 71% of their claims and optometrists filed 67% of their claims for brand-name drugs, together prescribing more than $2.4 billion in brand-name drugs in 2013.

Glaucoma medications accounted for the most prescriptions for any single category of ophthalmic drugs, accounting for 54%, or $1.2 billion, of the total and 72% of the total volume.

A switch to generic drugs for brand medications when available would save $148 million, the researchers said. Further savings potential of $882 million could be realized with a switch to a combination of generic drugs and therapeutic substitutions, according to the study.

However, the biggest savings, a 53% reduction in expenditures, could be seen if “Medicare negotiated ophthalmic drug prices similar to those negotiated by the federal government on behalf of the [United States Veterans Administration],” the authors wrote, decreasing total cost from $2.06 billion to $968 million, and saving $1.09 billion. – by Robert Linnehan

Disclosures: Newman-Casey reports she is a consultant for Blue Health Intelligence. Please see the study for all other authors’ relevant financial disclosures.